Month: October 2018
Medicaid enrollment fell by 0.6 percent in 2018 — its first drop since 2007 — due to the strong economy and increased efforts in some states to verify eligibility, a new report finds.
Twenty minutes before the only scheduled 2018 California’s gubernatorial debate, Lt. Gov. Gavin Newsom rolled into the San Francisco parking garage in a black SUV. Through the tinted windows, a soft overhead light slightly illuminated the front-runner’s chiseled features and slicked-back hair.
The Trump administration Monday took new steps to broaden the availability of health plans that don’t have to cover patients’ preexisting medical conditions, signaling that the federal government would support state proposals to promote more sales of these skimpier plans.
States would be able to use federal funding to provide subsidies to people buying short-term health insurance policies, which typically don’t provide comprehensive coverage, under guidance released Monday by the Trump administration.
The Trump administration is proposing to allow U.S. workers to use tax-free health reimbursement arrangements to shop for coverage in the individual market. It's another move aimed at expanding consumer choices and lowering costs for small businesses.
After a streak of steady declines, California’s uninsured rate bottomed out last year with some 2.7 million people still without health coverage.
The Trump administration’s top Medicare official Tuesday slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.
The CMS on Monday handed state governors significant power to overhaul their insurance exchanges and changed the way it will evaluate so-called innovation waivers.
Amazon has been in the headlines disrupting markets for years, but over the past few months, we have seen more and more news about the company’s ambitions in healthcare. From the alliance with JPMorgan Chase and Berkshire Hathaway that Dr. Atul Gawande has been appointed to lead to the purchase of PillPack, Amazon is clearly serious about healthcare. The question now is how far will Amazon, the master disrupter, take this?
President Trump wants to force drug companies to disclose their prices in TV ads — and that’s going to hit five companies much harder than any others: Pfizer, AbbVie, Eli Lilly, Amgen, and Allergan.